preview: priority review in multiple myeloma and 2016 esmo congress highlights
Published 8 years ago • 13 plays • Length 0:35Download video MP4
Download video MP3
Similar videos
-
6:42
priority review in multiple myeloma and 2016 esmo congress highlights
-
4:22
esmo 2019 myeloma highlights - defining optimal response in myeloma
-
9:07
esmo 2016 conference highlights
-
1:00
esmo 2022 highlights
-
3:06
what is minimal residual testing in multiple myeloma?
-
33:28
esmo 2022: highlights, commentary and analysis
-
1:55
new definition for multiple myeloma improves patient outcomes
-
1:00
what is multiple myeloma?
-
5:48
newly diagnosed multiple myeloma
-
2:23
dw-mri and serum biomarkers to assess tumor burden and bone loss in multiple myeloma
-
0:48
hemosure covid-19 rapid tests for professional screening of sars-cov-2 of igm/igg antibodies
-
2:33
results and impact of a patient-reported symptoms tool in multiple myeloma
-
8:31
what tests are used to assess response to treatment?
-
6:01
how to know when a re-biopsy is necessary for an advanced nsclc patient?
-
3:53
comparison of mrd and conventional imwg response assessment in the gem-cesar trial
-
4:25
is precision myeloma medicine more hype than reality?
-
8:31
what tests are used to assess response to treatment?
-
4:40
monitoring response and defining complete remission in multiple myeloma
-
3:25
refined diagnostic criteria for sos/vod in adult patients: 2023 update by the ebmt